tirzepatide surpass 4 for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Reduction of prevalence of patients

Clinical trials have shown that GLP-1 receptor agonists, particularly semaglutide and liraglutide, can reduce liver fat content and improve some markers of liver inflammation

The problem is that weight loss is notoriously difficult to achieve particularly with lifestyle modifications, such as diet and exercise, alone

The combined efforts of Wellstar's care teams and patients as part of the ERAS program proved a significant 24% reduction in 30-day readmissions, a 61% reduction in pain medications used, and a patient satisfaction rate of 99%

Research suggests cycles of up to 12 weeks with breaks in between to maintain efficacy and prevent tolerance

It helps regulate hormones, lower cholesterol, and makes you feel fuller